Cordis wins FDA approval for sirolimus-eluting balloon

Cordis has received FDA approval for a sirolimus-eluting balloon, providing physicians with an alternative to uncoated balloons and Boston Scientific's paclitaxel-coated device. This approval expands treatment options in the interventional cardiology space.